ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469
Luminex Corporation began a recall of ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469 on . FDA classified it as Class II and gives the reason as "Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-2286-2019
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Luminex Corporation
- Product
- ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469
- Product code
- PGX Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Reason for recall
- Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
- Root cause tag
- manufacturing process
- FDA root cause
- Process control
- Action
- On February 20, 2019, the firm sent a "Urgent: Medical Device Recall/Field Safety Notice" via email to all consignees. The customer notification informed customers of the following: 1. As an immediate action, Luminex is requesting that customers discontinue use of and discard the products listedin the recall notice immediately or by the Discontinue Use By date. Contact Luminex Global Support Services to obtain replacement material. Material that is still within its Discontinue Use By date may be used at the customers discretion. 2. Complete the Acknowledgment and Receipt form. You must complete and return this form even if you do not have any remaining product. Luminex Technical Support can assist you in completing this form. This information is essential in order to maintain recall effectiveness information required by US FDA. 3. Although no adverse events have been reported, adverse reaction or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax. 4. Please call the Luminex Global Support Services Team if you have any questions or concerns. Luminex Global Support Services 1-877-785-2323 (U.S. and Canada) +1-512-381-4397 (Outside U.S. and Canada) [email protected] CAN-0233
- Distribution
- US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom
- Product codes and lots
- Lot numbers & discontinue use by dates for Part Number 50-10041: AA7313 - Immediately; AA7526 - 3/7/2019; AA7605 - 3/9/2019; AA7631 - 4/3/2019; AA7645 - 4/12/2019
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2282-2019 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2283-2019 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2284-2019 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2285-2019 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2286-2019 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2287-2019 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2288-2019 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
